Flow cytometry of tumor cells suspensions showed specific labeling of CD38-positive cells with JK36AF680 in both saline-pretreated and daratumumab-pretreated mice and no specific labeling of CD38-negative tumor cells. This evidence concerns the gene CD38 and neoplasm.